Mydecine Innovations Group Inc (CSE: MYCO) (OTC: MYCOF) (FSE: 0NF), a Canada-based life sciences company, has named former Red Bull marketing executive, Jim Gunning, as its new chief marketing officer, it was reported on Friday.
Gunning has over two decades of experience in marketing. He has served as the managing director of RESQWATER and as a consultant for Blue Sky Biologicals.
In the new role, Gunning will be responsible for helping Mydecine to become a household name, and for developing a marketing campaign around the company's new fungtional mushroom product range under Mydecine Health Sciences, the company's operational branch. The fungtional mushroom product line should be on retail shelves across the US before the end of this year.
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers